Literature DB >> 7534137

Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.

E Knipping1, K M Debatin, K Stricker, B Heilig, A Eder, P H Krammer.   

Abstract

The cell-surface protein APO-1 is a member of the nerve growth factor (NGF)/tumor necrosis factor (TNF) receptor superfamily. APO-1 mediates apoptosis in susceptible cells upon stimulation with the monoclonal antibody anti-APO-1 or upon binding of its natural ligand. Soluble receptors had previously been identified for most members of the NGF/TNF receptor superfamily. Recently, a soluble form of APO-1 (sAPO-1) was described. We established a sandwich enzyme-linked immunosorbent assay to detect sAPO-1 in culture supernatants of human cell lines and in human sera. sAPO-1 was found in culture supernatants of different human B- and T-cell lines. Molecular weights of sAPO-1 and membrane APO-1 were similar. In addition, in comparison to healthy donors, sera from patients with different high- and low-grade malignant B- and T-cell leukemias and lymphomas contained increased levels of sAPO-1. These findings may have implications for the growth of leukemias and the diagnostic monitoring of individual patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534137

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Detection of human proteins using arrayed imaging reflectometry.

Authors:  Charles R Mace; Christopher C Striemer; Benjamin L Miller
Journal:  Biosens Bioelectron       Date:  2008-05-27       Impact factor: 10.618

Review 3.  Apoptosis in B-chronic lymphocytic leukaemia.

Authors:  L M Osorio; M Aguilar-Santelises
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

4.  Soluble Fas mRNA is dominantly expressed in cases with silicosis.

Authors:  T Otsuki; H Sakaguchi; A Tomokuni; T Aikoh; T Matsuki; Y Kawakami; M Kusaka; H Ueki; S Kita; A Ueki
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 5.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

6.  Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer.

Authors:  Enas A Hamed; Madeha M Zakhary; Doaa W Maximous
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

7.  Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus.

Authors:  U Felderhoff-Mueser; R Herold; F Hochhaus; P Koehne; E Ring-Mrozik; M Obladen; C Bührer
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

8.  Systemic immune response after laparoscopic and open cholecystectomy.

Authors:  Shyr-Ming Sheen-Chen; Han-Shiang Chen; Hock-Liew Eng; Wei-Jen Chen; Bruno Jawan
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

9.  Apoptosis and peripheral blood lymphocyte depletion in coeliac disease.

Authors:  A Di Sabatino; S D'Alò; D Millimaggi; R Ciccocioppo; R Parroni; G Sciarra; M G Cifone; G R Corazza
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

10.  Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.

Authors:  Azza E I El Bassiouny; Nora E I El-Bassiouni; Mona M F Nosseir; Mona M K Zoheiry; Eman G El-Ahwany; Faten Salah; Zeinab S O Omran; Raafat A Ibrahim
Journal:  Medscape J Med       Date:  2008-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.